Telix Pharmaceuticals Limited American Depositary Shares — Rendiconto Finanziario Trimestrale (NASDAQ:TLX) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi

Trimestrale Annuale

Market Capitalization 31.95 M
Employee 1 184
Founded 2015
CEO Christian Behrenbruch
Website www.telixpharma.com
Headquarter Australia
FIGI BBG01N69K900
Industry Biotecnologia